Industry Verticals »

All Categories

Insights »

About TMR »

Microfluidic Device System Market

Microfluidic Device System Market - Global Industry Analysis, Trend, Size, Share and Forecast 2016 - 2024

Global Microfluidic Device System Market: Snapshot

In the last few years, the developments of microfluidic components and tools have been enthralling for the life science and pharmaceutical industries. Moreover, further developments are seen by various developing analytical applications in the several end user industries. It has been the major technology to engineer microminiaturized medical devices. Though there are various uses of this technology, but popularity of microfluidic components have increased largely in making lab-on-a-chip system. In addition, various advantages of the microfluidic components is cheap and provides swift test results that has grown its importance for making biological and chemical analyses.Advancements made in point of care testing is likely to further expand the application of microfluidic device systems.

Other advantages of microfluidic components and tools has cheap cost of diagnostic procedures and limited use of reagents. Recently, microfluidic device system has observed numerous favorable applications in the areas of proteomics and genomics, creating many opportunities for players in the market.

The global microfluidic device system market is expected to expand at a healthy 22.8% CAGR throughout the forecast period between 2013 and 2019. During the projected period the market to touch US$5.2 bn by 2019.

Wide Application of Microfluidic Devices System to Boost Market Growth

The global microfluidic device system market is categorized on the basis of application, material, and industry type. The application of the microfluidic device system is seen in pharmaceuticals and life science, drug delivery, clinical and veterinary diagnostics, analytical devices, environmental and industrial, and point of care testing. Among these applications, clinical and veterinary diagnostic segment held the largest share in the market. However, it has been projected that in the coming years, the point of care testing segment could show a remarkable growth rate in the global microfluidic device system market over the forecast period.

According to the industry type, the market is segmented into pharmaceuticals, in-vitro diagnostics, and medical devices. Among these segments, the in-vitro diagnostics is the largest user of microfluidic device system and is expected to reach a valuation of US$ 3.3 bn by the end 2019. In addition, during the forecast tenure, the medical devices segment is also anticipated to increase the use of microfluidic device system that may boost the demand in the market. Based on type of material, the global market is further divided into glass, polymer, and silicon.

Low Cost Of Microfluidic Platforms In Point Of Care Testing To Rise In Developing Regions

On the regional front, the global microfluidic device system is categorized into North America, South America, Asia Pacific, Europe, and the Middle East and Africa. Out of these, North America possessed the key market share. Growing development of purpose-oriented and new microfluidic device systems are considered as the major factors for the growth the microfluidic device system market in the region.

In the meantime, the demand for medical devices is growing largely in Asia Pacific, whereas, point of care testing is the fastest growing application in the microfluidic device system market. Over the forecast period, Asia Pacific is anticipated to expand at a promising CAGR. Introduction of low-cost and portable microfluidic platforms in point of care testing in various emerging economies are supporting the growth of market in this region.

Based on the vendor landscape, the report has critically analyzed several leading players in the market. To mention a few players in the global microfluidic device system market are Abbott Laboratories, Becton Dickinson and Company, Siemens Healthcare, Agilent Technologies, Fluidigm Corporation, Roche Diagnostics, and Bio-Rad Laboratories.

    1. Preface

        1.1. Report Description

        1.2. Research Methodology

            1.2.1. Sources

                1.2.1.1. Secondary Research

                1.2.1.2. Primary Research

                1.2.1.3. Assumptions

    2. Executive Summary

    3. Industry Analysis

        3.1. Introduction

        3.2. Market Drivers and Opportunities

            3.2.1. Rising demand for point of care testing

            3.2.2. Miniaturization of chips, reduces cost of testing

            3.2.3. Increasing demand of microfluidic device in genomics and proteomics

            3.2.4. Change in material mix provides new opportunities for new players in the market

        3.3. Restraints and Challenges

            3.3.1. Strict regulatory requirements

            3.3.2. Geometrical and surface chemistry issues are a challenge for microfluidics

    4. Market Trends

        4.1. Rising number of collaborations and partnerships

        4.2. Rising number of product innovations

    5. Porters Five Force Analysis

        5.1. Bargaining power of buyers

        5.2. Bargaining power of suppliers

        5.3. Threat of new entrants

        5.4. Threat of substitutes

        5.5. Degree of competition

    6. Global Market Size and Forecast

    7. Segment Analysis – by Material

        7.1. Glass

        7.2. Polymer

        7.3. Silicon

    8. Segment Analysis – by Industry

        8.1. In-vitro diagnostics

        8.2. Pharmaceuticals

        8.3. Medical Devices

    9. Segment Analysis – by Application

        9.1. Point of care testing

        9.2. Pharmaceutical and life science research

        9.3. Drug delivery

        9.4. Analytical devices

        9.5. Clinical and veterinary diagnostics

        9.6. Environment and Industrial

    10. Regional Analysis

        10.1. North America

        10.2. Europe

        10.3. Asia

        10.4. Rest of the World

    11. Competitive Landscape

    12. Company Profiles

        12.1. Roche Diagnostics

            12.1.1. Overview

            12.1.2. Products and segment

            12.1.3. Financial Performance

            12.1.4. Strategic Development

        12.2. Abbott Laboratories

            12.2.1. Overview

            12.2.2. Products and segment

            12.2.3. Financial Performance

            12.2.4. Strategic Developments

        12.3. Siemens Healthcare

            12.3.1. Overview

            12.3.2. Products and segment

            12.3.3. Financial Performance

            12.3.4. Strategic Development

        12.4. Agilent Technologies Inc

            12.4.1. Overview

            12.4.2. Products and segment

            12.4.3. Financial Performance

        12.5. Fluidigm Corporation

            12.5.1. Overview

            12.5.2. Products and segment

            12.5.3. Financial Performance

            12.5.4. Strategic Developments

        12.6. Bio- Rad Laboratories

            12.6.1. Overview

            12.6.2. Products and segment

            12.6.3. Financial Performance

            12.6.4. Strategic Developments

        12.7. Cepheid

            12.7.1. Overview

            12.7.2. Products and segment

            12.7.3. Financial Performance

            12.7.4. Strategic Developments

        12.8. RainDance Technologies

            12.8.1. Overview

            12.8.2. Products and segment

            12.8.3. Financial Performance

            12.8.4. Strategic Development

        12.9. Dolomite Centre

            12.9.1. Overview

            12.9.2. Products and segment

            12.9.3. Financial Performance

            12.9.4. Strategic Developments

        12.10. Micronit Microfluidics

            12.10.1. Overview

            12.10.2. Products and segment

            12.10.3. Financial Performance

        12.11. Johnson & Johnson

            12.11.1. Overview

            12.11.2. Product Segment

            12.11.3. Financial Performance

        12.12. Becton, Dickinson and Company

            12.12.1. Overview

            12.12.2. Products and Segments

            12.12.3. Financial performance

            12.12.4. Strategic Developments

    List of Tables

    TABLE 1: Market Snapshot: microfluidic device market (2013 & 2019)

    TABLE 2: Drivers for microfluidic devices market: Impact analysis

    TABLE 3: Restraints for microfluidic devices market: Impact analysis

    TABLE 4: Major collaborations and partnerships by microfluidic device companies (2011-2013)

    TABLE 5: Some of the products launched by various companies

    TABLE 6: Global microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 7: Global microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 8: Global microfluidic devices market size, by material 2009-2012 (USD million)

    TABLE 9: Global microfluidic devices market size, by material 2013-2019 (USD million)

    TABLE 10: Global microfluidic devices market size, by industry 2009-2012 (USD million)

    TABLE 11: Global microfluidic devices market size, by industry 2013-2019 (USD million)

    TABLE 12: Global microfluidic devices market size, by application 2009-2012 (USD million)

    TABLE 13: Global microfluidic devices market size, by application 2013-2019 (USD million)

    TABLE 14: Glass microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 15: Glass microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 16: Polymer microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 17: Polymer microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 18: Silicon microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 19: Silicon microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 20: In-vitro diagnostic industry in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 21: In-vitro diagnostic industry in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 22: Pharmaceutical industry in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 23: Pharmaceutical industry in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 24: Pharmaceutical industry in microfluidic devices market size, by products 2009-2012 (USD million)

    TABLE 25: Pharmaceutical industry in microfluidic devices market size, by products 2013-2019 (USD million)

    TABLE 26: Chips for lab analytics in microfluidic devices market size, by products 2009-2012 (USD million)

    TABLE 27: Chips for lab analytics in microfluidic devices market size, by products 2013-2019 (USD million)

    TABLE 28: Medical devices industry in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 29: Medical devices industry in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 30: Medical devices industry in microfluidic devices market size, by products 2009-2012 (USD million)

    TABLE 31: Medical devices industry in microfluidic devices market size, by products 2013-2019 (USD million)

    TABLE 32: Point of care testing in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 33: Point of care testing in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 34: Pharmaceutical and life science research in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 35: Pharmaceutical and life science research in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 36: Drug delivery in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 37: Drug delivery in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 38: Analytical devices in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 39: Analytical devices in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 40: Clinical and veterinary diagnostics in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 41: Clinical and veterinary diagnostics in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 42: Environment and industrial application in microfluidic devices market size, by region 2009-2012 (USD million)

    TABLE 43: Environment and industrial application in microfluidic devices market size, by region 2013-2019 (USD million)

    TABLE 44: The North American microfluidic devices market size, by country 2009-2012 (USD million)

    TABLE 45: The North American microfluidic devices market size, by country 2013-2019 (USD million)

    TABLE 46: The European microfluidic devices market size, by country 2009-2012 (USD million)

    TABLE 47: The European microfluidic devices market size, by country 2013-2019 (USD million)

    TABLE 48: The Asian microfluidic devices market size, by country 2009-2012 (USD million)

    TABLE 49: The Asian microfluidic devices market size, by country 2013-2019 (USD million)

    TABLE 50: Roche Diagnostics major product categories

    TABLE 51: Abbott Laboratories major product categories

    TABLE 52: Siemens Healthcare major product categories

    TABLE 53: Agilent Technologies major product categories

    TABLE 54: Major Fluidigm Corporation products and its application

    TABLE 55: Major Bio-Rad laboratories products and categories

    TABLE 56: Major Cepheid products and categories

    TABLE 57: Major RainDance Technologies products and its applications

    TABLE 58: Major Dolomite Centre products and categories

    TABLE 59: Major Micronit Microfluidics products and categories

    TABLE 60: Major Johnson & Johnson segments and products

    TABLE 61: Major Becton, Dickinson and Company segments and products

    List of Figures

    FIG. 1: Applications of Microfluidics

    FIG. 2: Functions of Microfluidics

    FIG. 3: Aging population in major regions (% 2000-2050)

    FIG. 4: Microfluidic Device Market: Porters Five Force Analysis

    FIG. 5: Global microfluidic device market, by region 2013 (% share)

    FIG. 6: Global microfluidic device market, by material 2013 (% share)

    FIG. 7: Global microfluidic device market, by industry 2013 (% share)

    FIG. 8: Global microfluidic device market, by application 2013 (% share)

    FIG. 9: Glass microfluidic device market, by region 2013 (% share)

    FIG. 10: Polymer microfluidic device market, by region 2013 (% share)

    FIG. 11: Silicon microfluidic device market, by region 2013 (% share)

    FIG. 12: In-vitro diagnostics industry in microfluidic device market, by region 2013 (% share)

    FIG. 13: Pharmaceutical industry in microfluidic device market, by region 2013 (% share)

    FIG. 14: Pharmaceutical industry in microfluidic device market, by product 2013 (% share)

    FIG. 15: Chips for lab analytics in microfluidic device market, by product 2013 (% share)

    FIG. 16: Medical device industry in microfluidic device market, by region 2013 (% share)

    FIG. 17: Medical devices industry in microfluidic device market, by product 2013 (% share)

    FIG. 18: Microfluidic device material used in point of care testing in 2010 (% share)

    FIG. 19: Point of care testing in microfluidic device market, by region 2013 (% share)

    FIG. 20: Microfluidic device material in pharmaceutical and life science research in 2010 (% share)

    FIG. 21: Pharmaceutical and life science research in microfluidic device market, by region 2013 (% share)

    FIG. 22: Microfluidic device material in drug delivery in 2010 (% share)

    FIG. 23: Drug delivery in microfluidic device market, by region 2013 (% share)

    FIG. 24: Microfluidic device material in analytical devices in 2010 (% share)

    FIG. 25: Analytical Devices in microfluidic device market, by region 2013 (% share)

    FIG. 26: Microfluidic device material used in clinical and veterinary diagnosis in 2010 (% share)

    FIG. 27: Clinical and veterinary diagnosis in microfluidic device market, by region 2013 (% share)

    FIG. 28: Microfluidic device material in environment and industrial application in 2010 (% share)

    FIG. 29: Environment and industrial application in microfluidic device market, by region 2013 (% share)

    FIG. 30: The North American microfluidic device market, by country 2013 (% share)

    FIG. 31: The European microfluidic device market, by country 2013 (% share)

    FIG. 32: The Asian microfluidic device market, by country 2013 (% share)

    FIG. 33: Competitive landscape of global microfluidic device market

    FIG. 34: Roche sales and net income 2011-2013 (USD Million)

    FIG. 35: Abbott Laboratories net sales and net earnings 2011-2013 (USD Million)

    FIG. 36: Siemens revenue and net income 2011-2013 (USD Million)

    FIG. 37: Agilent Technologies revenue and net income 2011-2013 (USD Million)

    FIG. 38: Fluidigm Corporation total revenue and net income 2011-2013 (USD Million)

    FIG. 39: Bio-Rad Laboratories net sales and net income 2010-2012 (USD Million)

    FIG. 40: Cepheid sales and net income 2011-2013 (USD Million)

    FIG. 41: Johnson & Johnson sales and net earnings 2011-2013 (USD Million)

    FIG. 42: Becton, Dickinson and Company revenue and net income 2011-2013 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Microfluidic Device System Market

Schedule a Call